Polypeptides comprising a mutant non-structural Hepatitis C virus useful in diagnostic and/or immunogenic compositions are disclosed, in which the mutant is an N-terminal mutation that functionally disrupt the catalytic domain of NS3. Polynucleotides encoding these polypeptides, host cells transformed with polynucleotides and methods of using the polypeptides and polynucleotides are also disclosed.

 
Web www.patentalert.com

< Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants

< Macrocyclic peptides active against the hepatitis C virus

> Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents

> Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection

~ 00232